Vitamin D3 Priming of Dendritic Cells Shifts Human Neutrophil-Dependent Th17 Cell Development to Regulatory T Cells

Vitamin D3 (VD3) is a potential adjuvant for use in tolerogenic vaccine formulations that target dendritic cells (DCs) for the treatment of chronic inflammatory disorders, e.g., autoimmune diseases. These disorders are often associated with enhanced activity of IL-17-producing T helper 17 (Th17) cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafkamp, Florianne M. J., Taanman-Kueter, Esther W. M., van Capel, Toni M. M., Kormelink, Tom Groot, de Jong, Esther C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301463/
https://www.ncbi.nlm.nih.gov/pubmed/35874744
http://dx.doi.org/10.3389/fimmu.2022.872665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301463/
https://www.ncbi.nlm.nih.gov/pubmed/35874744
http://dx.doi.org/10.3389/fimmu.2022.872665

Ejemplares similares